Cohance Lifesciences Ltd 2025 Annual Report with Sustainability Disclosures
Company: Cohance Lifesciences Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 172
The report describes the company's FY2025 transformation into a technology-led global CDMO, supported by the acquisitions of NJ Bio and Sapala. Consolidated revenue from operations reached ₹1,197.58 crore, while the company reported a platform business of US$335 million on an annualised post-merger basis. The report also highlights approval of its targets by SBTi and a 30.48% reduction in absolute Scope 1 and Scope 2 emissions against the FY2023 baseline. Environmental initiatives include renewable-energy projects, water recycling, zero-liquid-discharge systems and waste-reduction measures.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.